Central Nervous System (CNS) therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Hypersomnia (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... utics under development for Hypersomnia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the the......" | 30-Apr-2021 | $2000 | |
MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... ugs in Development, 2021 provides an overview of the MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) pipeline landscape.
The report provides comprehensive information on the therapeutics under d......" | 30-Apr-2021 | $2000 | |
Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... s comprehensive information on the therapeutics under development for Opium Withdrawal Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also ......" | 30-Apr-2021 | $2000 | |
Panic Disorders (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... the therapeutics under development for Panic Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological A......" | 30-Apr-2021 | $2000 | |
Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... lerosis (SPMS) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Secondary Progressive Multiple Sclerosis (SPMS), complete with analysis by Stage of Development, Drug Target, Mech......" | 30-Apr-2021 | $2000 | |
Seizures (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... er development for Seizures, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, i......" | 30-Apr-2021 | $2000 | |
Smoking Cessation (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... ion on the therapeutics under development for Smoking Cessation, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacol......" | 30-Apr-2021 | $2000 | |
Spinal Stenosis (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... the therapeutics under development for Spinal Stenosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological A......" | 30-Apr-2021 | $2000 | |
Status Epilepticus (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... mation on the therapeutics under development for Status Epilepticus, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharm......" | 30-Apr-2021 | $2000 | |
Chemotherapy Induced Pain (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... s comprehensive information on the therapeutics under development for Chemotherapy Induced Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also ......" | 30-Apr-2021 | $2000 | |
|